
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Timothy Pabst, PhD, is senior scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

Published: October 2nd 2009 | Updated:

Published: March 2nd 2009 | Updated: